Government of Kenya   Report issue

Government Phase 3 Phase 4
Founded: Nairobi Kenya (1963)

Organization Overview

First Clinical Trial
2003
NCT00130065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Center for Disease Control and Prevention-Kenya | Centers for Disease Control and Prevention Kenya Country Office | Centers for Disease Control and Prevention, Kenya Medical Research Institiute | Centres for Disease Control and Prevention, Kenya. | Division of Malaria Control, Ministry of Health, Nairobi, Kenya | Ministry of Health, Kenya

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 14